Literature DB >> 9869828

Ossifying fibromyxoid tumor of soft parts: a report of 17 cases with emphasis on unusual histological features.

M Zámecník1, M Michal, R H Simpson, J Lamovec, P Hlavcák, Z Kinkor, P Mukensnábl, Z Matĕjovský, J Betlach.   

Abstract

Ossifying fibromyxoid tumor of soft parts is an unusual benign neoplasm, with a tendency for local recurrence. Its typical microscopic appearance is that of a multinodular proliferation of round to spindle shaped cells separated by fibrous bands in which bone formation is often seen. Herein, we present the clinicopathologic features of 17 examples of this tumor with particular emphasis on some unusual histopathologic features that may place pitfalls in the diagnosis of this tumor, including satellite micronodules, mucinous microcysts, absence of myxoid areas, crush artifact, multiple microcalcifications, epidermoid cysts, atypical chondroid differentiation with binucleate lacunar cells, pericytic growth pattern, and malignant change. Awareness of these unusual morphologic features should lead to a search for areas displaying the more typical features of ossifying fibromyxoid tumor to arrive at a correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9869828     DOI: 10.1016/s1092-9134(97)80011-1

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  10 in total

1.  Atypical ossifying fibromyxoid tumor unusually located in the mediastinum: report of a case showing mosaic loss of INI-1 expression.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Lei Zhang; Chun-Liang Chen; Shih-Chiang Huang; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2016-08-26       Impact factor: 5.006

3.  Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.

Authors:  Rondell P D Graham; Sarah Dry; Xinmin Li; Scott Binder; Armita Bahrami; Susana C Raimondi; Ahmet Dogan; Subhankar Chakraborty; Joshua J Souchek; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

4.  Ossifying fibromyxoid tumour: a rare soft tissue tumour of intermediate malignancy.

Authors:  F Binesh; A Akhavan; H Navabii
Journal:  BMJ Case Rep       Date:  2011-03-24

Review 5.  Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature.

Authors:  Kouji Ohta; Masayuki Taki; Ikuko Ogawa; Shigehiro Ono; Kuniko Mizuta; Shinichi Fujimoto; Takashi Takata; Nobuyuki Kamata
Journal:  Head Face Med       Date:  2013-06-24       Impact factor: 2.151

6.  Ossifying fibromyxoid tumor (OFMT) - A rare cause of a painful thumb.

Authors:  K Sharma; David Hughes; R D Harper
Journal:  Int J Surg Case Rep       Date:  2014-11-20

7.  Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report.

Authors:  Harri Foster-Davies; Zita M Jessop; Rachel M Clancy; Kerrin Vijayasurej; Johanne Vass; Thomas Bragg; Maurizio Brotto
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-23

8.  Malignant ossifying fibromyxoid tumor of the brain treated with post-operative fractionated stereotactic radiation therapy: A case report and literature review.

Authors:  Sasha Beyer; Nikhil T Sebastian; Rahul Neal Prasad; Jacqueline Chu; Kevin Liu; Kajal Madan; William Jiang; Jayeeta Ghose; Dukagjin M Blakaj; Joshua D Palmer; Mostafa Eltobgy; Jose Otero; James B Elder; Raju R Raval
Journal:  Surg Neurol Int       Date:  2021-11-30

9.  Malignant ossifying fibromyxoid tumor of the calvaria: illustrative case.

Authors:  Jan T Hachmann; R Scott Graham
Journal:  J Neurosurg Case Lessons       Date:  2021-08-23

Review 10.  Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.

Authors:  Ignacio A Velasco; Ran Zhang; Tiejun Li; Diancan Wang
Journal:  Diagn Pathol       Date:  2018-03-27       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.